The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.

Title

The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.

Creator

Geldenhuys Werner J; Van der Schyf Cornelis J

Publisher

Expert review of neurotherapeutics

Date

2009
2009-07

Description

The serotonin 6 receptor is attracting attention as an etiological contributor in cognition deficits in diseases such as Alzheimer's disease, anxiety/depression and schizophrenia. In this review, we discuss the role of this recently discovered G protein-coupled receptor in cognition and memory, particularly in Alzheimer's disease. A surge in publications that describe the development of ligands for this receptor have recently come to light, underscoring the emerging interest in this receptor as a drug target. We also explore the current status of structure-activity relationship studies that have focused on the design of novel antagonists for the serotonin 6 receptor.

Subject

Humans; Animals; Structure-Activity Relationship; Serotonin/*metabolism; Drug Design; Alzheimer Disease/*complications; Cognition Disorders/*drug therapy/*etiology; Serotonin Antagonists/chemistry/*therapeutic use; Receptors; Biological; Models

Identifier

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

1073–1085

Issue

7

Volume

9

Citation

Geldenhuys Werner J; Van der Schyf Cornelis J, “The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.,” NEOMED Bibliography Database, accessed November 27, 2021, https://neomed.omeka.net/items/show/5019.

Social Bookmarking